Vascular damage in a mouse model of diabetic retinopathy: Relation to neuronal and glial changes

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 11, 2005, Pages 4281-4287

  Feit Leichman, Rachel A ^a   Kinouchi, Reiko ^a,b   Takeda, Masumi ^a,b   Fan, Zhigang ^a   Mohr, Susanne ^c   Kern, Timothy S ^a,c   Chen, Dong Feng ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; BIOLOGICAL MARKER; CASPASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYME ACTIVATION; FLUORESCENCE; GENETIC MODEL; GLIA CELL; IMMUNOHISTOCHEMISTRY; MICROANGIOPATHY; MORPHOMETRICS; MOUSE; MUELLER CELL; NICK END LABELING; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA; RETINA DEGENERATION; RETINA GANGLION CELL; STREPTOZOCIN DIABETES; ANIMAL; C57BL MOUSE; CAPILLARY; CELL COUNT; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MICROGLIA; PATHOLOGY; RETINA BLOOD VESSEL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ASTROCYTES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CAPILLARIES; CASPASES; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICROGLIA; PERICYTES; RETINAL GANGLION CELLS; RETINAL VESSELS;

EID: 33644689817     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1361     Document Type: Article

References (38)

1. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242-260.
2. Archer DB. Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye. 1999;13:497-523.
3. Engerman RL, Kern TS. Retinopathy in animal models of diabetes. Diabetes Metab Rev. 1995;11:109-120.
4. Yu DY, Cringle SJ, Su EN, et al. Pathogenesis and intervention strategies in diabetic retinopathy. Clin Exp Ophthalmol. 2001;29:164-166.
5. Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203-1206.
6. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.
7. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000;41:1971-1980.
8. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102:783-791.
9. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2000;28:3-8.
10. Parisi V, Uccioli L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev. 2001;17:12-18.
11. Aizu Y, Oyanagi K, Hu J, Nakagawa H. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin- diabetic rats. Neuropathology. 2002;22:161-170.
12. Agardh E, Bruun A, Agardh CD. Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res. 2001;23:276-284.
13. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 1998;47:445-449.
14. Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes. 1998;47:815-820.
15. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci. 2000;41:3561-3568.
16. Kusner LL, Sarthy VP, Mohr S. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. Invest Ophthalmol Vis Sci. 2004;45:1553-1561.
17. Cuthbertson RA, Hopper JL, Mandel TE. Difference in effect of cultured fetal pancreas transplants on retinal and renal capillary basement membrane thickness in diabetic mice. Transplantation. 1989;48:218-223.
18. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci. 2005;46:1440-1444.
19. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
20. Agren A, Rehn G, Naeser P. Morphology and enzyme activities of the retinal capillaries in streptozotocin-diabetic mice. Acta Ophthalmol (Copenh). 1979;57:1065-1069.
21. Midena E, Segato T, Radin S, et al. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res. 1989;21:106-111.
22. Kern TS, Engerman RL. A mouse model of diabetic retinopathy. Arch Ophthalmol. 1996;114:986-990.
23. Martin PM, Roon P, Van Ells TK, et al. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
24. Ning X, Baoyu Q, Yuzhen L, et al. Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med. 2004;13:87-92.
25. Asnaghi V, Gerhardinger C, Hoehn T, et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;2:506-511.
26. Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51:1172-1179.
27. Kern TS, Engerman RL. Galactose-induced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci. 1995;36:490-496.
28. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
29. Bringmann A, Reichenbach A. Role of Müller cells in retinal degenerations. Front Biosci. 2001;6:E72-E92.
30. Chuang DM, Hough C, Senatorov VV. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2005;45:269-290.
31. Kowluru RA. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res. 2002;24:123-128.
32. Kowluru RA, Kowluru A. Erythrocyte sodium-potassium ATPase activity and thiol metabolism in genetically hyperglycemic mice. Metabolism. 1992;41:160-164.
33. Llewelyn JG, Thomas PK, Mirrlees DJ. Aldose reductase activity and myo-inositol levels in sciatic nerve and dorsal root ganglia of the diabetic mutant mouse [C57/BL/Ks (db/db)]. Metabolism. 1991;40:1084-1087.
34. Agardh CD, Agardh E, Hultberg B, Ahren B. Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries. J Diabetes Compl. 2000;14:146-153.
35. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA. 1995;92:2780-2784.
36. Robison WG Jr, Kador PF, Akagi Y, et al. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes. 1986;35:295-299.
37. Akita M, Mizuno K, Matsubara A, et al. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model. Acta Med Okayama. 1993;47:299-304.
38. Kojima K, Matsubara H, Harada T, et al. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats. Jpn J Ophthalmol. 1985;29:99-109.